The relationship of time-dose fractionation factors to complications in the treatment of pituitary tumors by irradiation.
D000172:Acromegaly / Q000532:radiotherapy; D000236:Adenoma / Q000532:radiotherapy*; D000239:Adenoma, Acidophil / Q000532:radiotherapy; D000238:Adenoma, Chromophobe / Q000532:radiotherapy; D000293:Adolescent; D000328:Adult; D000368:Aged; D001766:Blindness / Q000209:etiology*; D001927:Brain Diseases / Q000209:etiology; D002648:Child; D003480:Cushing Syndrome / Q000532:radiotherapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009336:Necrosis / Q000209:etiology; D009901:Optic Nerve Diseases / Q000209:etiology; D010911:Pituitary Neoplasms / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000209:etiology*; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy / Q000009:adverse effects; D012306:Risk; D013997:Time Factors